VI4 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Technology & OEM MomentumActive engagements in photon-counting and CT with multiple OEMs indicate durable product differentiation and pipeline depth. Winning OEM design-ins supports multi-year revenue streams, higher content per system, and stronger aftermarket attachment rates versus commodity components.
Debt RefinancingRefinancing that lowers interest costs and extends maturities materially improves financial flexibility. Reduced recurring interest burden supports operating cash flow, funds R&D/manufacturing ramp, and lowers refinancing risk over the next several quarters.
India Manufacturing RampA completed India detector factory provides structural cost and capacity advantages as utilization rises. Local production can lower COGS, shorten lead times, and support margin expansion sustainably as volumes scale toward targeted utilization.
Bears Say
Negative Cash GenerationA recent reversal to negative operating and free cash flow reduces runway for investments and increases reliance on financing. If cash burn persists, the company may face constraints funding capex, working-capital needs, or R&D without further liquidity actions.
Deteriorating ProfitabilityTransition from multi-year profitability to negative EBIT/EBITDA and widened net losses signals weakened operating leverage or elevated costs. Sustained margin pressure undermines cash flow conversion and makes funding growth initiatives harder without structural cost recovery.
Working Capital StrainRising inventory and longer days of inventory tie up cash and raise obsolescence risk in a technology business. Combined with lower cash balances, this creates near-term liquidity pressure and signals forecasting or demand timing mismatches that can drag margins.
Varex Imaging News
VI4 FAQ
What was Varex Imaging Corporation’s price range in the past 12 months?
Currently, no data Available
What is Varex Imaging Corporation’s market cap?
Varex Imaging Corporation’s market cap is CHF381.03M.
When is Varex Imaging Corporation’s upcoming earnings report date?
Varex Imaging Corporation’s upcoming earnings report date is Aug 10, 2026 which is in 7 days.
How were Varex Imaging Corporation’s earnings last quarter?
Varex Imaging Corporation released its earnings results on May 07, 2026. The company reported CHF0.17 earnings per share for the quarter, the consensus estimate of CHF0.17 by CHF0.
Is Varex Imaging Corporation overvalued?
According to Wall Street analysts Varex Imaging Corporation’s price is currently Undervalued.
Does Varex Imaging Corporation pay dividends?
Varex Imaging Corporation does not currently pay dividends.
What is Varex Imaging Corporation’s EPS estimate?
Varex Imaging Corporation’s EPS estimate is 0.17.
How many shares outstanding does Varex Imaging Corporation have?
Currently, no data Available
What happened to Varex Imaging Corporation’s price movement after its last earnings report?
Varex Imaging Corporation reported an EPS of CHF0.17 in its last earnings report, expectations of CHF0.17. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Varex Imaging Corporation?
Currently, no hedge funds are holding shares in CH:VI4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Varex Imaging Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-19.76%
Trailing 12-Months
Company Description
Varex Imaging Corporation
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
VI4 Company Deck
VI4 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted solid execution on guidance, margin resilience (non‑GAAP gross margin at the high end), successful debt refinancing and clear technology and industrial pipeline momentum (CT, photon-counting, cargo systems). Offsetting these positives are modest top‑line growth (+1% YoY), a GAAP loss, margin erosion versus the prior year (down ~240 bps), elevated inventory and short‑term working capital pressures. Management provided multi-quarter visibility (annual guidance) and actions (India ramp, pricing/contract renewal levers) that could improve margins over time, but near-term growth and margin recovery remain modest.View all CH:VI4 earnings summariesVI4 Stock 12 Month Forecast
All Analysts
Top Analysts











